Published in Indian J Crit Care Med on March 01, 2017
APACHE II: a severity of disease classification system. Crit Care Med (1985) 69.83
The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med (2003) 32.30
Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008. Crit Care Med (2008) 31.57
The pathophysiology and treatment of sepsis. N Engl J Med (2003) 21.67
The immunopathogenesis of sepsis. Nature (2002) 11.83
Fluid resuscitation in septic shock: a positive fluid balance and elevated central venous pressure are associated with increased mortality. Crit Care Med (2011) 6.79
Pathogenetic mechanisms of septic shock. N Engl J Med (1993) 6.64
Cardiac filling pressures are not appropriate to predict hemodynamic response to volume challenge. Crit Care Med (2007) 4.21
Profound but reversible myocardial depression in patients with septic shock. Ann Intern Med (1984) 3.81
Lactate and venoarterial carbon dioxide difference/arterial-venous oxygen difference ratio, but not central venous oxygen saturation, predict increase in oxygen consumption in fluid responders. Crit Care Med (2013) 3.72
Has the mortality of septic shock changed with time. Crit Care Med (1998) 3.29
Fluid challenges in intensive care: the FENICE study: A global inception cohort study. Intensive Care Med (2015) 3.27
Actual incidence of global left ventricular hypokinesia in adult septic shock. Crit Care Med (2008) 2.92
Mechanisms of sepsis-induced cardiac dysfunction. Crit Care Med (2007) 2.79
Plasma brain natriuretic peptide as a biochemical marker of high left ventricular end-diastolic pressure in patients with symptomatic left ventricular dysfunction. Am Heart J (1998) 2.51
Surviving the first hours in sepsis: getting the basics right (an intensivist's perspective). J Antimicrob Chemother (2011) 2.31
An observational study fluid balance and patient outcomes in the Randomized Evaluation of Normal vs. Augmented Level of Replacement Therapy trial. Crit Care Med (2012) 2.27
A circulating myocardial depressant substance in humans with septic shock. Septic shock patients with a reduced ejection fraction have a circulating factor that depresses in vitro myocardial cell performance. J Clin Invest (1985) 2.26
Rapid transcriptional activation and early mRNA turnover of brain natriuretic peptide in cardiocyte hypertrophy. Evidence for brain natriuretic peptide as an "emergency" cardiac hormone against ventricular overload. J Clin Invest (1995) 2.15
The burden of sepsis-associated mortality in the United States from 1999 to 2005: an analysis of multiple-cause-of-death data. Crit Care (2009) 1.99
N-terminal pro-B-type natriuretic peptide is an independent predictor of outcome in an unselected cohort of critically ill patients. Crit Care Med (2007) 1.87
Impaired plasma B-type natriuretic peptide clearance in human septic shock. Crit Care Med (2008) 1.59
Septic cardiomyopathy - A not yet discovered cardiomyopathy? Exp Clin Cardiol (2006) 1.36
Assessment of volume responsiveness during mechanical ventilation: recent advances. Crit Care (2013) 1.35
What is a fluid challenge? Curr Opin Crit Care (2011) 1.14
Fluid management in acute respiratory distress syndrome. Curr Opin Crit Care (2013) 0.91
Updates in the management of acute lung injury: a focus on the overlap between AKI and ARDS. Adv Chronic Kidney Dis (2013) 0.86
Choosing patient-tailored hemodynamic monitoring. Crit Care (2010) 0.85
Pharmacological treatment of sepsis. Fundam Clin Pharmacol (2008) 0.80
[Sepsis and heart]. Internist (Berl) (2010) 0.79